tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

CAS NO.：1118767-16-0

Purity ： 99%
Appearance：White solid

Product Name	tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu
Synonyms	(S)-22-(Tert-butoxycarbonyl)-10,19,24-trioxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontane-1,41-dioicacid;Octadecane(OtBu)-Glu(ɑ-OtBu)-AEEA-AEEA-OH;Sidechain;tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu;SemaglutiChemicalbookdesidechain;Fmoc-L-Lys[OctotBu)-Glu-(otBu)-AEEA-AEEA]-OHu;(S)-22-(tert-butoxycarbonyl)-43,43-dimethyl-10,19,24,41-tetraoxo-3,6,12,15,42-pentaoxa-9,18,23-triazatetratetracontanoicacid;Egf(a)analogue-13C4
CAS NO	1118767-16-0
Purity	99%
MF	C43H79N3O13
MW	846.1
Contact	windy@coreychem.com

Pharmacological Actions
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu exerts its pharmacological effects by activating the GLP-1 receptor. GLP-1 is a hormone secreted by intestinal L cells that promotes insulin secretion and inhibits glucagon secretion, thereby lowering blood glucose levels. Upon binding to the GLP-1 receptor, tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu mimics the biological activity of GLP-1, promoting insulin secretion and inhibiting glucagon secretion, thereby lowering blood glucose levels. Furthermore, tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu can suppress appetite and slow gastric emptying, helping to control weight and improve metabolic status.
Uses
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu is a novel diabetes treatment that has been widely used clinically. Furthermore, the semaglutide side chain has the potential to reduce weight and cardiovascular risk, offering additional health benefits to diabetic patients.

1G/5G/10G/100G per bottle;

Or package according to customer needs

Get a quote

CAS NO.: 70-18-8